A molecular hypothesis to explain direct and inverse co-morbidities between Alzheimer's Disease, Glioblastoma and Lung cancer

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Sánchez Valle, Jon ^a   Tejero, Héctor ^a   Ibáñez, Kristina ^b   Portero, José Luis ^c   Krallinger, Martin ^a   Al Shahrour, Fátima ^a   Tabarés Seisdedos, Rafael ^d   Baudot, Anaïs ^e   Valencia, Alfonso ^a,f,g  

^a Centro Nacional de Investigaciones Oncológicas   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ IDIPAZ   (Spain)

^c CEU Universities   (Spain)

^d UNIVERSITY OF VALENCIA   (Spain)

^e AIX MARSEILLE UNIVERSITÉ   (France)

^f BARCELONA SUPERCOMPUTING CENTER   (Spain)

^g INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; REACTIVE OXYGEN METABOLITE;

ALZHEIMER DISEASE; BIOLOGICAL MODEL; COMORBIDITY; DISEASE PREDISPOSITION; GENE EXPRESSION; GENETIC VARIATION; GENETICS; GLIOBLASTOMA; HUMAN; LUNG TUMOR; METABOLISM; SIGNAL TRANSDUCTION;

ALZHEIMER DISEASE; BIOMARKERS; COMORBIDITY; DISEASE SUSCEPTIBILITY; GENE EXPRESSION; GENETIC VARIATION; GLIOBLASTOMA; HUMANS; LUNG NEOPLASMS; MODELS, BIOLOGICAL; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 85021668982     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-04400-6     Document Type: Article

References (71)

1. Catalá-López, F., Genova-Maleras, R., Vieta, E. & Tabarés-Seisdedos, R. The increasing burden of mental and neurological disorders. Eur. Neuropsychopharmacol. 23, 1337-9 (2013)
2. Underwood, E. NEUROSCIENCE. Alzheimer's amyloid theory gets modest boost. Science 349, 464 (2015)
3. Ramalingam, S. S., Owonikoko, T. K. & Khuri, F. R. Lung cancer: New biological insights and recent therapeutic advances. CA. Cancer J. Clin. 61, 91-112
4. Woehrer, A., Bauchet, L. & Barnholtz-Sloan, J. S. Glioblastoma survival: has it improved Evidence from population-based studies. Curr. Opin. Neurol. 27, 666-74 (2014)
5. Tabarés-Seisdedos, R. & Rubenstein, J. L. Inverse cancer comorbidity: a serendipitous opportunity to gain insight into CNS disorders. Nat. Rev. Neurosci. 14, 293-304 (2013)
6. Tabarés-Seisdedos, R. et al. No paradox, no progress: inverse cancer comorbidity in people with other complex diseases. Lancet. Oncol. 12, 604-8 (2011)
7. Lehrer, S. Glioblastoma and dementia may share a common cause. Med. Hypotheses 75, 67-68 (2010)
8. Driver, J. A. et al. Inverse association between cancer and Alzheimer's disease: results from the Framingham Heart Study. BMJ 344, e1442 (2012)
9. Musicco, M. et al. Inverse occurrence of cancer and Alzheimer disease: a population-based incidence study. Neurology 81, 322-8 (2013)
10. Ou, S.-M. et al. Does Alzheimer's disease protect against cancers A nationwide population-based study. Neuroepidemiology 40, 42-9 (2013)
11. Tabarés-Seisdedos, R. & Baudot, A. Editorial: Direct and Inverse Comorbidities Between Complex Disorders. Front. Physiol 7 (2016)
12. Ibánez, K., Boullosa, C., Tabarés-Seisdedos, R., Baudot, A. & Valencia, A. Molecular evidence for the inverse comorbidity between central nervous system disorders and cancers detected by transcriptomic meta-analyses. PLoS Genet. 10, e1004173 (2014)
13. Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545-50 (2005)
14. Lonsdale, J. et al. The Genotype-Tissue Expression (GTEx) project. Nat. Genet. 45, 580-585 (2013)
15. Reimand, J., Kull, M., Peterson, H., Hansen, J. & Vilo, J. g:Profiler-a web-based toolset for functional profiling of gene lists from large-scale experiments. Nucleic Acids Res. 35, W193-200 (2007)
16. Hidalgo, C. A., Blumm, N., Barabási, A.-L. & Christakis, N. A. A Dynamic Network Approach for the Study of Human Phenotypes. PLoS Comput. Biol. 5, e1000353 (2009)
17. Bahn, S. et al. Gene expression profiling in the post-mortem human brain-no cause for dismay. J. Chem. Neuroanat. 22, 79-94 (2001)
18. Li, J. Z. et al. Systematic changes in gene expression in postmortem human brains associated with tissue pH and terminal medical conditions. Hum. Mol. Genet 13, 609-16 (2004)
19. Tomita, H. et al. Effect of agonal and postmortem factors on gene expression profile: quality control in microarray analyses of postmortem human brain. Biol. Psychiatry 55, 346-352 (2004)
20. Bruna, J., Miró, J. & Velasco, R. Epilepsy in glioblastoma patients: basic mechanisms and current problems in treatment. Expert Rev. Clin. Pharmacol 6, 333-344 (2013)
21. Schouten, L. J., Rutten, J., Huveneers, H. A. M. & Twijnstra, A. Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. Cancer 94, 2698-705 (2002)
22. Nayak, L., Lee, E. Q. & Wen, P. Y. Epidemiology of brain metastases. Curr. Oncol. Rep. 14, 48-54 (2012)
23. Takahashi, K., Takahashi, F., Hirama, M., Tanabe, K. K. & Fukuchi, Y. Restoration of CD44S in non-small cell lung cancer cells enhanced their susceptibility to the macrophage cytotoxicity. Lung Cancer 41, 145-53 (2003)
24. Yoshida, T., Matsuda, Y., Naito, Z. & Ishiwata, T. CD44 in human glioma correlates with histopathological grade and cell migration. Pathol. Int. 62, 463-70 (2012)
25. Akiyama, H., Tooyama, I., Kawamata, T., Ikeda, K. & McGeer, P. L. Morphological diversities of CD44 positive astrocytes in the cerebral cortex of normal subjects and patients with Alzheimer's disease. Brain Res. 632, 249-59 (1993)
26. Uberti, D. et al. Increased CD44 gene expression in lymphocytes derived from Alzheimer disease patients. Neurodegener. Dis. 7, 143-7 (2010)
27. Goto, Y. et al. UCHL1 provides diagnostic and antimetastatic strategies due to its deubiquitinating effect on HIF-1. Nat. Commun. 6, 6153 (2015)
28. Deighton, R. F. et al. The proteomic response in glioblastoma in young patients. J. Neurooncol. 119, 79-89 (2014)
29. Takami, Y. et al. Ubiquitin carboxyl-terminal hydrolase L1, a novel deubiquitinating enzyme in the vasculature, attenuates NFkappaB activation. Arterioscler. Thromb. Vasc. Biol. 27, 2184-90 (2007)
30. Zhang, M., Cai, F., Zhang, S., Zhang, S. & Song, W. Overexpression of ubiquitin carboxyl-terminal hydrolase L1 (UCHL1) delays Alzheimer's progression in vivo. Sci. Rep. 4, 7298 (2014)
31. Moreira, P. I., Carvalho, C., Zhu, X., Smith, M. A. & Perry, G. Mitochondrial dysfunction is a trigger of Alzheimer's disease pathophysiology. Biochim. Biophys. Acta 1802, 2-10 (2010)
32. Upadhya, S. C. & Hegde, A. N. Role of the ubiquitin proteasome system in Alzheimer's disease. BMC Biochem. 8(Suppl 1), S12 (2007)
33. Liang, W. S. et al. Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons. Proc. Natl. Acad. Sci. USA 105, 4441-6 (2008)
34. Maruszak, A. & ekanowski, C. Mitochondrial dysfunction and Alzheimer's disease. Prog. Neuropsychopharmacol. Biol. Psychiatry 35, 320-30 (2011)
35. Silva, D. F. F., Esteves, A. R., Oliveira, C. R. & Cardoso, S. M. Mitochondria: the common upstream driver of amyloid-and tau pathology in Alzheimer's disease. Curr. Alzheimer Res. 8, 563-72 (2011)
36. Saharan, S. & Mandal, P. K. The emerging role of glutathione in Alzheimer's disease. J. Alzheimers. Dis. 40, 519-29 (2014)
37. Blair, S. L. et al. Glutathione metabolism in patients with non-small cell lung cancers. Cancer Res. 57, 152-5 (1997)
38. Manolopoulos, K. N., Klotz, L.-O., Korsten, P., Bornstein, S. R. & Barthel, A. Linking Alzheimer's disease to insulin resistance: the FoxO response to oxidative stress. Mol. Psychiatry 15, 1046-52 (2010)
39. Maekawa, T. et al. Expression and localization of FOXO1 in non-small cell lung cancer. Oncol. Rep. 22, 57-64 (2009)
40. Essers, M. A. G. et al. FOXO transcription factor activation by oxidative stress mediated by the small GTPase Ral and JNK. EMBO J. 23, 4802-12 (2004)
41. Ho, K. K., Myatt, S. S. & Lam, E. W.-F. Many forks in the path: cycling with FoxO. Oncogene 27, 2300-11 (2008)
42. Coppede, F. & Migliore, L. DNA damage and repair in Alzheimer's disease. Curr. Alzheimer Res. 6, 36-47 (2009)
43. Cron, K. R. et al. Proteasome inhibitors block DNA repair and radiosensitize non-small cell lung cancer. PLoS One 8, e73710 (2013)
44. Shokolenko, I., Venediktova, N., Bochkareva, A., Wilson, G. L. & Alexeyev, M. F. Oxidative stress induces degradation of mitochondrial DNA. Nucleic Acids Res. 37, 2539-48 (2009)
45. Zismanov, V., Drucker, L. & Gottfried, M. Combined inhibition of Hsp90 and the proteasome affects NSCLC proteostasis and attenuates cell migration. Anticancer. Drugs 25, 998-1006 (2014)
46. Cabeza-Arvelaiz, Y. & Schiestl, R. H. Transcriptome analysis of a rotenone model of parkinsonism reveals complex I-tied and-untied toxicity mechanisms common to neurodegenerative diseases. PLoS One 7, e44700 (2012)
47. Catalá-López, F. et al. Inverse and direct cancer comorbidity in people with central nervous system disorders: a meta-analysis of cancer incidence in 577,013 participants of 50 observational studies. Psychother. Psychosom. 83, 89-105 (2014)
48. Ong, E. L. H., Goldacre, R. & Goldacre, M. Differential risks of cancer types in people with Parkinson's disease: a national recordlinkage study. Eur. J. Cancer 50, 2456-62 (2014)
49. Serrano, J., Fernández, A. P., Martínez-Murillo, R. & Martínez, A. High sensitivity to carcinogens in the brain of a mouse model of Alzheimer's disease. Oncogene 29, 2165-71 (2010)
50. Brennan, C. W. et al. The Somatic Genomic Landscape of Glioblastoma. Cell 155, 462-477 (2013)
51. Racker, E. Bioenergetics and the problem of tumor growth. Am. Sci. 60, 56-63
52. Atamna, H. & Kumar, R. Protective role of methylene blue in Alzheimer's disease via mitochondria and cytochrome c oxidase. J. Alzheimers. Dis. 20(Suppl 2), S439-52 (2010)
53. Poteet, E. et al. Reversing the Warburg effect as a treatment for glioblastoma. J. Biol. Chem. 288, 9153-64 (2013)
54. Pathak, D. et al. The Role of Mitochondrially Derived ATP in Synaptic Vesicle Recycling. J. Biol. Chem. 290, 22325-36 (2015)
55. Stewart, C. R. et al. CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat. Immunol. 11, 155-61 (2010)
56. Miklossy, J. Chronic inflammation and amyloidogenesis in Alzheimer's disease-role of Spirochetes. J. Alzheimers. Dis. 13, 381-91 (2008)
57. Deleidi, M. & Isacson, O. Viral and inflammatory triggers of neurodegenerative diseases. Sci. Transl. Med. 4, 121ps3 (2012)
58. Lu, H., Ouyang, W. & Huang, C. Inflammation, a key event in cancer development. Mol. Cancer Res. 4, 221-33 (2006)
59. Solinas, G., Germano, G., Mantovani, A. & Allavena, P. Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation. J. Leukoc. Biol. 86, 1065-73 (2009)
60. Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015)
61. McCall, M. N., Jaffee, H. A. & Irizarry, R. A. fRMA ST: frozen robust multiarray analysis for Affymetrix Exon and Gene ST arrays. Bioinformatics 28, 3153-4 (2012)
62. Ashburner, M. et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 25, 25-9 (2000)
63. Ramanan, V. K., Shen, L., Moore, J. H. & Saykin, A. J. Pathway analysis of genomic data: concepts, methods, and prospects for future development. Trends Genet. 28, 323-32 (2012)
64. Matthews, L. et al. Reactome knowledgebase of human biological pathways and processes. Nucleic Acids Res. 37, D619-22 (2009)
65. McCall, M. N., Bolstad, B. M. & Irizarry, R. A. Frozen robust multiarray analysis (fRMA). Biostatistics 11, 242-253 (2010)
66. Ramasamy, A., Mondry, A., Holmes, C. C. & Altman, D. G. Key issues in conducting a meta-analysis of gene expression microarray datasets. PLoS Med. 5, e184 (2008)
67. Gautier, L., Cope, L., Bolstad, B. M. & Irizarry, R. A. affy-analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 20, 307-15 (2004)
68. Wang, X. et al. An R package suite for microarray meta-analysis in quality control, differentially expressed gene analysis and pathway enrichment detection. Bioinformatics 28, 2534-6 (2012)
69. Khaitovich, P. Regional Patterns of Gene Expression in Human and Chimpanzee Brains. Genome Res. 14, 1462-1473 (2004)
70. Tan, P. P. C., French, L. & Pavlidis, P. Neuron-Enriched Gene Expression Patterns are Regionally Anti-Correlated with Oligodendrocyte-Enriched Patterns in the Adult Mouse and Human Brain. Front. Neurosci. 7, 5 (2013)
71. Iorio, F. et al. Discovery of drug mode of action and drug repositioning from transcriptional responses. Proc. Natl. Acad. Sci. 107, 14621-14626 (2010).